Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...
Please provide your email address to receive an email when new articles are posted on . Decreases in mental health scores after glaucoma diagnosis may be associated with fears of vision loss or ...
Nucleoside and nucleotide reverse transcriptase inhibitors use remained significantly associated with an increased risk for developing primary open-angle glaucoma after adjustment for family history.
TUESDAY, July 8, 2025 (HealthDay News) -- Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results